ECAN Advocates Convince Congress to Include Esophageal Cancer in a Multi-Million Dollar Research Fund
For the second year in a row, thousands of ECAN advocates made their voices heard and convinced lawmakers in the [...]
FDA Approves First Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
The U.S. Food and Drug Administration has approved Keytruda (Pembrolizumab) for treatment of advanced Esophageal Squamous Cell Carcinoma (ESCC). It [...]
First Step Toward Millions in Research Funding!
The Appropriations Committee of the U.S. House of Representatives has included Esophageal Cancer in a multi-million dollar Cancer Research Fund! [...]
The Start of Esophageal Cancer Awareness Month
A message from ECAN's President, CEO and Founder Mindy Mintz Mordecai about the ten-year anniversary of Esophageal Cancer [...]
Stop Esophageal Cancer Before it Starts with the WATS3D® Brush Biopsy
WATS3D detects potentially dangerous cells so they don’t progress to cancer. Clinical studies show that adding WATS3D to [...]